Work

Figure S3 from APOBEC3 Activity Promotes the Survival and Evolution of Drug-Tolerant Persister Cells during EGFR Inhibitor Resistance in Lung Cancer

Year: 2025

Type: other

Abstract: PC9 cells expressing APOBEC3B maintain high APOBEC activity following resistance to gefitinib.

DOI: 10.1158/2767-9764.29118184

Authors: Nina Marie G. Garcia, Jessica N. Becerra, Sharan Srinivasan, Brock J. McKinney, Ashley V. DiMarco, Feinan Wu, Matthew Fitzgibbon, James V. Alvarez

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4410565981

Cites:

Cited by:

Related to: 10